Advertisement
UK markets closed

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     

  • CRUDE OIL

    78.92
    +0.44 (+0.56%)
     

  • GOLD FUTURES

    2,322.10
    -9.10 (-0.39%)
     

  • DOW

    38,930.80
    +78.53 (+0.20%)
     

  • Bitcoin GBP

    50,727.65
    +83.92 (+0.17%)
     

  • CMC Crypto 200

    1,314.76
    -50.37 (-3.69%)
     

  • NASDAQ Composite

    16,387.61
    +38.37 (+0.23%)
     

  • UK FTSE All Share

    4,522.99
    +53.90 (+1.21%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Johnson & Johnson to test experimental HIV vaccine in U.S., Europe

Reuters
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

(Reuters) - Johnson & Johnson <JNJ.N> said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

The drugmaker already has a mid-stage HIV vaccine study underway in five southern African countries.

There are currently no vaccines for HIV, a virus that weakens the body's immune system.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)